BRPI0811140A2 - processos melhorados para produção de hidrazidas - Google Patents

processos melhorados para produção de hidrazidas

Info

Publication number
BRPI0811140A2
BRPI0811140A2 BRPI0811140A BRPI0811140A BRPI0811140A2 BR PI0811140 A2 BRPI0811140 A2 BR PI0811140A2 BR PI0811140 A BRPI0811140 A BR PI0811140A BR PI0811140 A BRPI0811140 A BR PI0811140A BR PI0811140 A2 BRPI0811140 A2 BR PI0811140A2
Authority
BR
Brazil
Prior art keywords
improved processes
hydrazide
production
hydrazide production
processes
Prior art date
Application number
BRPI0811140A
Other languages
English (en)
Inventor
Ayman Sahli
George A Chiarello
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI0811140A2 publication Critical patent/BRPI0811140A2/pt
Publication of BRPI0811140B1 publication Critical patent/BRPI0811140B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/04—Preparation of hydrazides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coating Apparatus (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0811140-5A 2007-05-22 2008-05-20 Processos melhorados para produção de hidrazidas BRPI0811140B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93952907P 2007-05-22 2007-05-22
US60/939.529 2007-05-22
PCT/US2008/064213 WO2008147765A1 (en) 2007-05-22 2008-05-20 Improved processes for making hydrazides

Publications (2)

Publication Number Publication Date
BRPI0811140A2 true BRPI0811140A2 (pt) 2015-10-27
BRPI0811140B1 BRPI0811140B1 (pt) 2022-08-16

Family

ID=39810161

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811140-5A BRPI0811140B1 (pt) 2007-05-22 2008-05-20 Processos melhorados para produção de hidrazidas

Country Status (24)

Country Link
US (5) US8110705B2 (pt)
EP (2) EP2155258B1 (pt)
JP (4) JP5697446B2 (pt)
KR (1) KR101547705B1 (pt)
CN (2) CN102558001B (pt)
AR (1) AR066674A1 (pt)
AU (1) AU2008256905B2 (pt)
BR (1) BRPI0811140B1 (pt)
CA (1) CA2687852A1 (pt)
CL (1) CL2008001490A1 (pt)
CY (2) CY1119373T1 (pt)
DK (2) DK2465541T3 (pt)
ES (2) ES2642888T3 (pt)
HU (2) HUE036704T2 (pt)
IL (1) IL202242A (pt)
MX (1) MX2009012587A (pt)
PA (1) PA8781201A1 (pt)
PE (1) PE20090305A1 (pt)
PL (2) PL2155258T3 (pt)
PT (2) PT2465541T (pt)
SI (2) SI2155258T1 (pt)
TW (1) TW200904784A (pt)
WO (1) WO2008147765A1 (pt)
ZA (1) ZA200908229B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5697446B2 (ja) * 2007-05-22 2015-04-08 ワイス・エルエルシー ヒドラジドを製造するための改善されたプロセス
RU2016119491A (ru) 2013-11-04 2017-12-11 Пфайзер Инк. Конъюгаты антитела к efna4 с лекарственным средством
SI3066074T1 (sl) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediati in postopki za sintetizacijo derivatov kaliheamicina
SMT202100146T1 (it) 2014-04-30 2021-05-07 Pfizer Coniugati di anticorpo anti-ptk7-farmaco
US10135670B2 (en) * 2014-12-22 2018-11-20 Hewlett Packard Enterprise Development Lp Response to an inoperative network device managed by a controller
WO2019018647A1 (en) 2017-07-20 2019-01-24 Pfizer Inc. ANTI-GD3 ANTIBODIES AND CONJUGATES ANTIBODY-MEDICATION
WO2019069931A1 (ja) 2017-10-03 2019-04-11 公立大学法人大阪府立大学 細胞培養容器、細胞の取得方法、および細胞の培養方法
CN109574870A (zh) * 2018-12-25 2019-04-05 维思普新材料(苏州)有限公司 一种酰肼的连续制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US623230A (en) * 1899-04-18 Rotary ore-cooler
DE2608336A1 (de) 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4291022A (en) 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4671958A (en) 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4479953A (en) 1983-08-25 1984-10-30 Merck & Co., Inc. Pyrazine aldimine compounds as antimicrobial agents
US4970198A (en) 1985-10-17 1990-11-13 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
US4729781A (en) 1986-08-04 1988-03-08 Sandoz Ltd. 3,6-dichloro-2-methoxybenzohydroxamic acid derivatives and use as herbicidal agents
EP0255800B1 (en) 1986-08-04 1991-07-17 Sandoz Ag Benzohydroxamic acid derivatives
US4939244A (en) 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
US5079233A (en) 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5053394A (en) 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5770701A (en) 1987-10-30 1998-06-23 American Cyanamid Company Process for preparing targeted forms of methyltrithio antitumor agents
JPH05222044A (ja) 1991-10-25 1993-08-31 Eastman Kodak Co 2当量ピラゾロトリアゾールマゼンタカプラーの製造
DE69217085T2 (de) * 1991-11-22 1997-05-28 Uniroyal Chem Co Inc Insekttötende phenylhydrazin-derivate
US5690904A (en) * 1993-07-12 1997-11-25 Amersham International Plc Diagnostic radiopharmaceutical compounds (That)
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
US5403015A (en) * 1993-12-09 1995-04-04 Forte; Steven L. Cards and methods for playing casino 21 or blackjack
WO1996006096A1 (en) 1994-08-23 1996-02-29 Nissan Chemical Industries, Ltd. Pyridine derivative
IT1292092B1 (it) 1997-06-05 1999-01-25 Geange Ltd Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
DE69936998T2 (de) 1998-10-16 2008-05-21 Merck Sharp & Dohme Ltd., Hoddesdon Pyrazolotriazinderivate als gaba-rezeptorliganden
GB0008696D0 (en) 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
US7041685B2 (en) 2001-06-08 2006-05-09 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
BR122019027966B8 (pt) * 2002-05-02 2021-07-27 Wyeth Corp conjugado monomérico de derivado de caliqueamicina/anti-corpo anti-cd22 e uso dos mesmos
US6803379B2 (en) 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
JP2006516250A (ja) 2002-12-18 2006-06-29 サイトビア インコーポレイティッド カスパーゼ活性化剤およびアポトーシス誘導物質としての3,5−二置換−[1,2,4]−オキサジアゾールおよびそれらの誘導体ならびにそれらの使用
PT1572215E (pt) 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
JP2006528694A (ja) * 2003-05-13 2006-12-21 スミスクライン ビーチャム コーポレーション ナフチリジンインテグラーゼインヒビター
US20060009493A1 (en) 2003-07-02 2006-01-12 Sugen, Inc. Indolinone hydrazides as c-Met inhibitors
CA2531061A1 (en) 2003-07-02 2005-01-13 Vertex Pharmaceuticals Incorporated Pyrimidines useful as modulators of voltage-gated ion channels
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
CA2563316A1 (en) * 2004-04-06 2005-10-20 Semafore Pharmaceuticals, Inc. Pten inhibitors
TW200630106A (en) * 2004-10-08 2006-09-01 Wyeth Corp Immunotherapy of autoimmune disorders
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
JP5697446B2 (ja) * 2007-05-22 2015-04-08 ワイス・エルエルシー ヒドラジドを製造するための改善されたプロセス

Also Published As

Publication number Publication date
AR066674A1 (es) 2009-09-02
EP2465541A1 (en) 2012-06-20
US9738602B2 (en) 2017-08-22
PL2465541T3 (pl) 2018-12-31
WO2008147765A1 (en) 2008-12-04
JP2017193584A (ja) 2017-10-26
ES2686019T3 (es) 2018-10-16
ES2642888T3 (es) 2017-11-20
EP2155258A1 (en) 2010-02-24
US20160176809A1 (en) 2016-06-23
ZA200908229B (en) 2010-08-25
CY1119373T1 (el) 2018-02-14
PT2155258T (pt) 2017-10-18
EP2155258B1 (en) 2017-08-16
US20130211053A1 (en) 2013-08-15
EP2465541B1 (en) 2018-07-18
JP2016026219A (ja) 2016-02-12
JP5697446B2 (ja) 2015-04-08
DK2465541T3 (en) 2018-09-17
PE20090305A1 (es) 2009-03-15
TW200904784A (en) 2009-02-01
AU2008256905B2 (en) 2014-05-08
KR101547705B1 (ko) 2015-08-26
HK1172008A1 (zh) 2013-04-12
CL2008001490A1 (es) 2008-07-25
CA2687852A1 (en) 2008-12-04
CY1120592T1 (el) 2019-12-11
SI2465541T1 (sl) 2018-10-30
PA8781201A1 (es) 2008-12-18
AU2008256905A1 (en) 2008-12-04
KR20100031514A (ko) 2010-03-22
PL2155258T3 (pl) 2017-12-29
BRPI0811140B1 (pt) 2022-08-16
HUE039657T2 (hu) 2019-01-28
US8853451B2 (en) 2014-10-07
SI2155258T1 (sl) 2017-10-30
US20120130052A1 (en) 2012-05-24
HUE036704T2 (hu) 2018-07-30
CN102558001A (zh) 2012-07-11
JP2010528031A (ja) 2010-08-19
US8383857B2 (en) 2013-02-26
HK1147736A1 (en) 2011-08-19
CN102558001B (zh) 2015-09-23
DK2155258T3 (en) 2017-09-18
CN101835494B (zh) 2012-02-15
IL202242A0 (en) 2010-06-16
PT2465541T (pt) 2018-10-17
CN101835494A (zh) 2010-09-15
IL202242A (en) 2016-03-31
US20150099865A1 (en) 2015-04-09
JP2013234203A (ja) 2013-11-21
US8110705B2 (en) 2012-02-07
MX2009012587A (es) 2010-05-14
RU2009143524A (ru) 2011-06-27
US20080312422A1 (en) 2008-12-18
US9227924B2 (en) 2016-01-05

Similar Documents

Publication Publication Date Title
BRPI0813903A2 (pt) Processos para a prepração de pirazóis
DE602008003347D1 (de) Tonerverfahren
PT2639223T (pt) Processos para produção de ácidos cicloalquilcarboxamido-piridinabenzoicos
BRPI0818546A2 (pt) Misturas de enzimas para fermentação
BRPI0810482A2 (pt) Métodos de produção de proteína usando compostos antissenescência
DK3216802T3 (da) Produktionsfremgangsmåde
BRPI0906764A2 (pt) Processos
BRPI0819238A2 (pt) Métodos para a produção de caseína
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI0922490A2 (pt) Método para produção de beta-santaleno
EP2120677A4 (en) IMPROVED LIGHT BALANCE PROCESS
BRPI0920621A2 (pt) processos para síntese de composto macrolidos
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
PT2223114T (pt) Calibrante para imunoensaios
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0813858A2 (pt) Método para produzir peptídeo
DK2346661T3 (da) Dannelsesfremgangsmåder
BRPI0818674A2 (pt) Método para produção de anticorpos
EP2169142A4 (en) METHOD FOR MANUFACTURING FLOOR
BRPI0810656A2 (pt) Produto hidroformado
FR2918983B1 (fr) Procede de preparation de dinitrotoluene
BRPI0813861A2 (pt) processos de produção de estireno
BRPI0813482A2 (pt) Processo para preparar dimetacrilatos de butanodiol

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: "PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 47/48

Ipc: C07C 319/20 (2006.01), A61K 47/68 (2017.01), C07C

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 47/48; C07C 241/04; C07C 243/28; C07C 323/48.

Ipc: C07C 319/20 (2006.01), A61K 47/68 (2017.01), C07C

Ipc: C07C 319/20 (2006.01), A61K 47/68 (2017.01), C07C

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.